舍曲林抗烟曲霉活性的体内评估
本研究在蜡螟幼虫和小鼠侵袭性肺曲霉病模型中评估舍曲林单药的抗真菌活性。舍曲林在10和15 mg/kg剂量下改善幼虫存活和健康指数,10 mg/kg可降低肺部真菌负荷,疗效与3 mg/kg两性霉素B和10 mg/kg伏立康唑相当。这是首个评估舍曲林抗烟曲霉体内活性的研究,提示其可能作为肺曲霉病的辅助治疗选项。
要点
- 舍曲林10和15 mg/kg改善蜡螟幼虫存活和健康指数。
- 舍曲林10 mg/kg降低小鼠肺部真菌负荷,疗效与两性霉素B 3 mg/kg及伏立康唑10 mg/kg相当。
- 舍曲林可能作为肺曲霉病的辅助治疗选项,但需进一步临床验证。
核心结论
- 舍曲林在两种体内模型中显示抗烟曲霉活性,可能为肺曲霉病辅助治疗的有前景选项。
研究设计与样本
- 在蜡螟幼虫和小鼠侵袭性肺曲霉病模型中评估舍曲林单药三个剂量(3、10和15 mg/kg)的抗真菌活性。
主要发现
- 舍曲林10和15 mg/kg改善幼虫存活和健康指数。
- 舍曲林10 mg/kg降低小鼠肺部真菌负荷,疗效与3 mg/kg两性霉素B和10 mg/kg伏立康唑相当。
临床怎么用
- 舍曲林可能作为肺曲霉病的辅助治疗选项,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive pulmonary aspergillosis is a life-threatening fungal disease principally caused by the ubiquitous mould Aspergillus fumigatus. This clinical entity is a major cause of morbidity and mortality (principally, but not restricted to, immunocompromised individuals). A few recent reports suggest in vitro fungicidal activity of sertraline against Aspergillus spp., but this activity has not yet been investigated in vivo. OBJECTIVES: To evaluate the antifungal activity of sertraline in two in vivo models of aspergillosis. METHODS: The antifungal activity of sertraline as monotherapy at three different doses (3, 10 and 15 mg/kg) was evaluated in Galleria mellonella and in a murine model of invasive pulmonary aspergillosis. Therapeutic efficacy parameters determined were larval survival and health index score for G. mellonella, whereas pulmonary fungal burden, galactomannan and lung histopathology were assessed in the murine model. RESULTS: Sertraline treatments improved larval survival and health index score, especially at doses of 10 and 15 mg/kg. Moreover, 10 mg/kg sertraline was able to reduce pulmonary fungal burden with an efficacy comparable with that of 3 mg/kg amphotericin B and 10 mg/kg voriconazole. CONCLUSIONS: To the best of our knowledge, this is the first in vivo study that evaluates the antifungal activity of sertraline against A. fumigatus, showing a possible promising option for the adjuvant treatment of pulmonary aspergillosis.
引用
- Treviño-Rangel RJ, Villanueva-Lozano H, Méndez-Galomo KS, et al. In vivo evaluation of the antifungal activity of sertraline against Aspergillus fumigatus. J Antimicrob Chemother. 2019. PMID: 30403787. doi:10.1093/jac/dky455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。